APU
GENE

Alpine Partners USVI’s Genetic Technologies Ltd. GENE Stock Holding History

Alpine Partners USVI’s Portfolio GENE Stock Details GENE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		$4K Buy
+111
New +$4.45K 0.01% 100
2014
Q2 		$12K Hold
111
– – 0.1% 12
2014
Q1 		$16K Hold
111
– – 0.03% 11
2013
Q4 		$16K Sell
111
-100
-47% -$18.6K 0.08% 24
2013
Q3 		$49K Buy
211
+110
+109% +$26.2K 0.18% 30
2013
Q2 		$23K Buy
+101
New +$26.2K 0.01% 182

Other funds holding GENE

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TDC
Thompson Davis & Co Richmond, Virginia $150M AUM 32.35% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Alpine Partners USVI's GENE Position: Q4 2014 in Review

Alpine Partners USVI opened a new position in Genetic Technologies Ltd. (GENE) in Q4 2014: 111 shares worth $4K. The stake represents 0.01% of the portfolio and ranks #100 among its holdings. This is a return to the name: Alpine Partners USVI previously reported a position in GENE as recently as Q2 2014.

Alpine Partners USVI first reported a position in GENE in Q2 2013 and has held it in 6 quarters since. The position peaked at $49K in Q3 2013. 5 funds tracked by Wall St. Rank hold GENE as of Q4 2014.

  • Alpine Partners USVI held 111 shares of Genetic Technologies Ltd. worth $4K as of Q4 2014.
  • Genetic Technologies Ltd. was a new Alpine Partners USVI position in Q4 2014.
  • Genetic Technologies Ltd. made up 0.01% of Alpine Partners USVI's portfolio in Q4 2014, its #100 holding.
  • Alpine Partners USVI first reported a position in Genetic Technologies Ltd. in Q2 2013 and has held it in 6 quarters since.
  • Alpine Partners USVI's Genetic Technologies Ltd. position peaked at $49K in Q3 2013.
  • 5 funds tracked by Wall St. Rank held Genetic Technologies Ltd. as of Q4 2014.

Based on Alpine Partners USVI's 13F filing for Q4 2014, filed 12 Feb 2015.